Potential roles of other FK 506-binding proteins in mediating the effects of FK 506.
Siekierka
J J
JJ
Department of Immunology Research, Merck, Sharp & Dohme Research Laboratories, Rahway, NJ 07065.
Wiederrecht
G
G
Cryan
J
J
Hung
S H
SH
Comisky
M
M
Sigal
N H
NH
D000591:Amino Acid Isomerases / Q000378:metabolism; D002352:Carrier Proteins / Q000378:metabolism / Q000502:physiology*; D002460:Cell Line; D016572:Cyclosporine / Q000378:metabolism; D006801:Humans; D007165:Immunosuppression Therapy; D019696:Peptidylprolyl Isomerase; D013601:T-Lymphocytes; D016559:Tacrolimus / Q000378:metabolism / Q000494:pharmacology*; D022021:Tacrolimus Binding Proteins
D002352:Carrier Proteins; D016572:Cyclosporine; D000591:Amino Acid Isomerases; D022021:Tacrolimus Binding Proteins; D019696:Peptidylprolyl Isomerase; D016559:Tacrolimus